Results 221 to 230 of about 175,835 (341)

Pharmacological and Mechanistic Interventions for Cognitive Impairment Associated With Schizophrenia: A Review of Registered Clinical Trials

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background Schizophrenia is characterized by positive, negative, and cognitive symptoms. Current pharmacological treatments often fail to address cognitive deficits. In this review of clinical trials, we aim to identify studies that explore neurobiological (non‐psychological) strategies to address Cognitive Impairment Associated with ...
Bahareh Peyrovian, Lena Palaniyappan, Theodore T. Kolivakis, Howard C. Margolese   +3 more
wiley   +1 more source

Analysis of risk factors for postoperative recurrence in patients with chronic rhinosinusitis with nasal polyps: A retrospective clinical cohort study. [PDF]

Medicine (Baltimore)
Ji J, Yu J, Zhang C, Liu L, Li X, Da Y, Song J.   +6 more
europepmc   +1 more source

Buspirone maintenance does not alter the reinforcing, subjective, and cardiovascular effects of intranasal methamphetamine

, 2017
Anna R. Reynolds, Justin C. Strickland, William W. Stoops, Joshua A. Lile, Craig R. Rush   +4 more
openalex   +2 more sources

5‐Methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) for alcohol use disorder: An open‐label, phase 2, proof‐of‐concept, clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psychedelic drugs may help treat alcohol use disorder (AUD). This study evaluated BPL‐003, a novel intranasal powder formulation of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) benzoate salt, in people with moderate–severe AUD enrolled in a standard of care, 10‐week programme of relapse‐prevention oriented Cognitive ...
John Marsden, Michael Kelleher, Fiona Dunbar, Anna O. Ermakova, Luke Mitcheson, Claire Roberts, James J. Rucker, Gemma Scott, Ivan Saeger, Francesca Small, Mathieu Seynaeve   +10 more
wiley   +1 more source

Intranasal vaccination with probiotic Escherichia coli membrane vesicles displaying pneumococcal capsular polysaccharides elicits mucosal immunity. [PDF]

NPJ Vaccines
Nakao R, Kimura S, Abe K, Yamaguchi T, Kuroda E, Hamaguchi S, Tateda K, Ohki Y, Narisawa N, Ohnishi M, Akeda Y.   +10 more
europepmc   +1 more source

Hippocampal subfield differences in people with and without recreational ketamine use: Insights from multi‐modal neuroimaging

Addiction, EarlyView.
Abstract Background and aims Recreational ketamine use has increased globally and is associated with psychiatric and cognitive concerns. The hippocampus in preclinical models shows damage and working‐memory disruption with repeated dosing. However, whether specific hippocampal subregions may differ in people with chronic ketamine use remains unclear ...
Yi‐Hsuan Liu, Chia‐Chun Hung, Marc N. Potenza, Kun‐Hsien Chou, Pei‐Lin Lee, Chu‐Chung Huang, Chiang‐Shan R. Li, Tony Szu‐Hsien Lee, Ching‐Po Lin   +8 more
wiley   +1 more source

Chinese expert consensus on intranasal anticholinergics for allergic rhinitis. [PDF]

Asia Pac Allergy
Li X, Wang X, Yang Q, Chen J, Tian H, Lu M, Ma T, Zhang Y, Zhou Y, Xia J, Cheng L, Li J, Liu H, Liu J, Liu Z, Lv W, Qiu Q, Wang C, Wang X, Xu Y, Xu Y, Yang Y, Ye J, Yu H, Zhu D, Zhang Y, Zhang L.   +26 more
europepmc   +1 more source

Intranasal Midazolam Versus Intravenous Diazepam for the Treatment of Acute Seizures in Paediatric Patients

, 2015
Pooja Garg, R. S. Sethi, Aradhna Kankane, OS Chaurasia, Anuj Sethi   +4 more
openalex   +1 more source

Pharmacological treatment strategies to manage precipitated withdrawal following the administration of buprenorphine in opioid use disorder: A systematic review

Addiction, EarlyView.
Abstract Background and aims There has been limited evidence synthesis examining the treatment of buprenorphine precipitated opioid withdrawal (BPOW). We aimed to conduct the first systematic review to assess the clinical utility of any pharmacological intervention in the management of BPOW.
Emmert Roberts, Nicola Kalk, John Strang
wiley   +1 more source

Intranasal delivery of iron chelators and management of central nervous system disease. [PDF]

Front Pharmacol
Cheng R, Kim J.
europepmc   +1 more source